Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRS Group Regulatory News (RS1)

Share Price Information for RS Group (RS1)

Share Price is delayed by 15 minutes
Get Live Data
620.00    0.00 (0.00%)
Bid:
619.50
Ask:
620.50
Spread: 1.00 (0.161%)
Market Cap: £2.87b
RS1 Live PriceLast checked at - London Stock Exchange

Intraday RS Group Share Chart

Director/PDMR Shareholding

2 Jul 2025 09:00

RNS Number : 3116P
RS Group PLC
02 July 2025
 

RS GROUP PLC

("the Company")

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company makes the following notifications pursuant to the UK Market Abuse Regulation.

 

1 .

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Kate Ringrose

2.

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3.

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

RS Group plc

b)

 

LEI

 

549300KVXDURRKVW7R37

4.

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

10 pence ordinary shares

 

Identification code

GB0003096442

b)

 

Nature of the transaction

 

 

Vesting of:

- Conditional buy-out awards of Shares granted on 14 November 2023 under the Company's Long Term Incentive Plan 2022 and associated dividend equivalent Shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

12,527

Nil

504

d)

 

Aggregated information

- Aggregated volume

13,031

- Price

Nil

e)

 

Date of the transaction

 

 

2025-06-30

f)

 

Place of the transaction

 

 

Outside a trading venue

4.

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

10 pence ordinary shares

 

Identification code

GB0003096442

b)

 

Nature of the transaction

 

 

Sale of shares to cover tax liabilities and sale costs arising on vesting of:

- conditional buy-out awards of Shares granted on 14 November 2023 under the Company's Long Term Incentive Plan 2022 and associated dividend equivalent Shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 5.805

6,143

d)

 

Aggregated information

- Aggregated volume

6,143

- Price

GBP 35,660.12

 

e)

 

Date of the transaction

 

 

2025-06-30

f)

 

Place of the transaction

 

 

London Stock Exchange

XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUQUMUPAPPG
Date   Source Headline
17th Jun 202610:00 amRNSHolding(s) in Company
15th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 202612:00 pmRNSAnnual Financial Report and Notice of AGM
8th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 202610:00 amRNSDirector/PDMR Shareholding
2nd Jun 20263:55 pmRNSDirector Declaration
1st Jun 202612:43 pmRNSHolding(s) in Company
1st Jun 20269:44 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:01 amRNSCommencement of Share Buyback Programme
20th May 20267:00 amRNSFinal Results
1st Apr 20265:06 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSPre-Close Trading Update
3rd Mar 20267:00 amRNSAcquisition of BPX Group
6th Jan 20264:00 pmRNSDirector/PDMR Shareholding
12th Dec 20253:14 pmRNSDirectorate change
4th Dec 202510:00 amRNSDirector/PDMR Shareholding
20th Nov 20254:20 pmRNSReplacement Holding(s) in Company
20th Nov 20253:30 pmRNSHolding(s) in Company
7th Nov 20253:56 pmRNSHolding(s) in Company
6th Nov 20257:00 amRNSHalf-year Financial Report
1st Sep 20254:30 pmRNSHolding(s) in Company
12th Aug 20254:30 pmRNSHolding(s) in Company
8th Aug 20254:00 pmRNSHolding(s) in Company
1st Aug 202511:02 amRNSBlock listing Interim Review
21st Jul 20254:00 pmRNSDirector/PDMR Shareholding
17th Jul 20253:15 pmRNSResult of AGM
17th Jul 20257:00 amRNSAGM Update
4th Jul 202510:00 amRNSDirectorate Change - Chair of Audit Committee
2nd Jul 20259:00 amRNSDirector/PDMR Shareholding
23rd Jun 20259:00 amRNSDirector/PDMR Shareholding
18th Jun 20254:30 pmRNSDirector/PDMR Shareholding
10th Jun 202511:00 amRNSHolding(s) in Company
9th Jun 202512:00 pmRNSAnnual Financial Report and Notice of AGM
6th Jun 20252:00 pmRNSDirector/PDMR Shareholding
29th May 202510:00 amRNSDirector/PDMR Shareholding
21st May 20257:00 amRNSFinal Results
23rd Apr 20254:30 pmRNSDirector/PDMR Shareholding
28th Mar 20252:30 pmRNSDirector/PDMR Shareholding
26th Mar 202511:00 amRNSDirector/PDMR Shareholding
21st Feb 202510:00 amRNSDirectorate Change
3rd Feb 202510:39 amRNSBlock listing Interim Review
28th Jan 20257:00 amRNS3rd Quarter Trading Update
8th Jan 20259:13 amRNSDirector Declaration
7th Jan 20252:38 pmRNSDirector Declaration
29th Nov 20248:30 amRNSDirectorate Change
7th Nov 20247:00 amRNSHalf-year Report
1st Oct 20249:46 amRNSTotal Voting Rights
24th Sep 20247:00 amRNSInvestor Event: The RS Opportunity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.